A microbial strain sold for 1000 million yuan.

近日，一则新闻在生物制造圈与农化圈掀起不小波澜——Sichuan Agricultural University exclusively licensed a patented strain to Nanjing Red Sun Shares for 1000 million yuan., officially named "Red Sun Subspecies".

In the biomanufacturing sector, technology transfer deals worth tens of millions are not unprecedented. Yet, it's remarkable that a single microbial strain commands such a high valuation:Why is this strain worth 1000 million? What industry logic does it reflect?

The technical "value" behind [ 1000 ] ten thousand yuan.

The lethal power of a single bacterial strain

此次交易的是Patented Strain HS18-1It is not a fleeting "paper strain" confined to the lab. It is a mature engineered strain developed over many years by Professor Zheng Aiping's team at Sichuan Agricultural University, belonging to Bacillus thuringiensis—a prestigious family of bacteria in the biopesticide industry.

HS18-1Broad-spectrum insecticidal activity，可同时防治鳞翅目害虫、蚜虫和螨虫等多类农业重大虫害，直击化学农药抗性难题，对稻二化螟、玉米螟、草地贪夜蛾和棉铃虫等重大虫害的防效高。

此外，这株菌的商业化路径，并非简单的菌液喷洒，而是提取其产生的多肽蛋白作为农药有效成分，这种机制既保证了高效的杀虫活性，又在生态安全性上大大优于化学农药。

TRL 8级：从论文到工厂的"最后一公里"

It's not just the spectrum of efficacy that matters. The most critical value anchor behind the 1000 million price tag is...HS18-1 Technology Readiness Level (TRL) — 8 or higher。

The TRL framework consists of 9 levels, providing a systematic approach to assess a technology's progression from basic principles to mature application. TRL 8 signifies that the final design is complete, the product has passed all development testing and evaluation, and it is ready for small-batch production—enabling enterprises to confidently advance subsequent capacity building.

从红太阳的落地计划来看，This strain will establish an intelligent fermentation production line with an annual capacity of 2 million tons within 3 years.，首款"杀虫蛋白农药"有望在2027年获得农药登记证并上市After the project reaches full production capacity, the estimated annual sales revenue will be8亿元and drive the development of supporting industries, with an estimated additional associated output value50 billion yuan or more。

1000万元的转让费用，仅仅是这株菌完整商业价值链条上的一个微小注脚。

[ 交易背后：红太阳的战略卡位] .

红太阳，曾是南京前首富杨寿海一手创建的农药帝国。成立于1989年，从一个小型农药分装厂起家，历经30余年发展成为世界前五强的环保农药领军企业。但红太阳也在2022年开始经历了一场惊心动魄的破产重整后，不仅成功化解了历史遗留问题，更是在新国九条实施之后完成的首个上市公司成功重整

This 1000 million yuan investment in bacterial strains is just the tip of the iceberg for Red Sun's strategic transformation.2022年重整之后，红太阳迫切需要一条"第二增长曲线"。2025年，公司成立"中央研究院"，正在推进生物酶法K胺、多抗霉素等多个生物技术项目；2026年4月，新成立控股子公司"江苏华洲生物工程有限公司"，定位为公司在绿色农业与合成生物领域的关键产业载体。

The emergence of the "Red Sun Subspecies" strain has helped Red Sun take a crucial step forward:从"化学农药为主"向"化学与生物并举"的产品结构转型，终于有了一个看得见的抓手。

[ Why Now? ]

The convergence of policy, technology, and market forces

Policy-Driven: National Mandate to Reduce Chemical Pesticide Use

化学农药的滥用，已在中国引发严重的抗性危机。数据显示，我国约40%的农药品种具有高环境生态风险，50%以上的传统品种面临中高抗性风险，化学农药依存度仍超过90%Following the Ministry of Agriculture and Rural Affairs' release of the "Chemical Pesticide Reduction Action Plan for 2025," substituting chemical pesticides with biopesticides has become a prevailing trend.

Amid rising concerns over food safety and environmental pressure, insecticidal protein pesticides like HS18-1 offer a new approach. Estimates show thatThis biopesticide can replace 30%–50% of chemical pesticides.Saves 20-30 yuan per mu per season on pesticide and application costs.

Tech Breakthrough: The Fundamental Shift Driven by Synthetic Biology

Recent breakthroughs in synthetic biology are emerging at a rapid pace.Prof. Liu Liming's team from Jiangnan UniversitySet a world record for the highest productivity of PDA biosynthesis (130 g/L);中国科学院天津工业生物技术研究所The High-Throughput Editing and Screening Platform Lab developed and optimized a broad-spectrum β-lactam biosensor, integrated it with droplet microfluidics, and applied it to high-throughput screening of Cephalosporin C-producing strains.Tianmu BiotechnologyLaunch the next-generation automated high-throughput strain breeding platform, integrating droplet microfluidics with automation. Leverage droplet microfluidics to reduce data dimensionality for million-level mutant libraries, and utilize an automated system to complete re-screening, validation, and preservation in a seamless workflow.

一个不可忽视的趋势是：AI and automation are reshaping the cost curve of strain development, transforming the industry's underlying dynamics.。传统育种手段周期长、费用高、效率低，而合成生物学结合高通量筛选，将菌株开发从"手工作坊时代"推向了"工业化时代"。菌株开发效率的大幅提升，意味着更多优质菌种将像HS18-1一样，以更低的成本和更短的时间进入产业化通道。

Market Size: Trillion-dollar growth opportunity

Market data and forecasts indicate that the global advanced strain engineering microbial platform market reached $1 billion in 2025 and is projected to hit $3 billion by 2032. The precision fermentation market is also experiencing rapid growth, with the application of mature chassis strains like yeast accelerating across food, feed, and pharmaceutical sectors.

Specifically for the biopesticide sector，预测生全球生物农药市场规模预计将从2023年的68亿美元增长至2026年的112亿美元，年复合增长率达到16.5%，这一增长轨迹显著高于传统化学农药3%左右的增速，Reflects the urgent market demand for environmentally friendly plant protection solutions.

We can see that菌株知识产权正在成为生物制造时代的"硬通货"These strains, developed with complete independent intellectual property rights, are becoming the core weapon for various industries to break through the bottleneck of "strain chokeholds."

Based on this,The 2026 BIO-TECH Manufacturing Industry Expo will be held grandly in Shanghai from 8/27-28.This exhibition is organized by Yimao Medical. Invited guests will be present on-site, including:2000+Attendee,150+ Speaker,50+Premium exhibitors, featuring "Exhibitions - Products - Conferences - PartnershipsFour core modules focused on "breakthroughs in fundamental research and cross-sector industrialization," establishing a benchmark event for the entire bio-manufacturing value chain.